Many patients prescribed Ozempic or similar GLP-1 receptor agonist drugs to treat diabetes or support weight management have reported severe and prolonged vomiting, stomach paralysis, intestinal obstruction, and other serious gastrointestinal injuries
In sICH patients, GLP-1-RAs decreased hydrocephalus (OR 0.37, p = 0.005) and seizures (OR 0.56, p = 0.007) at 6 months, with persistent benefits at 1 year (hydrocephalus, OR 0.38, p = 0.007
[17] Papp LV, Lu J, Holmgren A, Khanna KK
Real-world example: hair loss after weight-loss, supported with targeted haircare Consider a 42-year-old woman who loses 15% of her body weight within six months of starting a GLP-1 injection
J Am Geriatr Soc 1992;40:1197-204
To validate the results of in silico screen, the enzymatic assays of top-4 selected natural compounds were measured